{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:46:54Z","timestamp":1792522014744,"version":"4.5.0"},"reference-count":30,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Somatic mutations in UBA1 cause vacuoles, E1 ubiquitin-activating enzyme, X-linked, autoinflammatory somatic (VEXAS) syndrome, an adult-onset inflammatory disease with an overlap of hematologic manifestations. VEXAS syndrome is characterized by a high mortality rate and significant clinical heterogeneity. We sought to determine independent predictors of survival in VEXAS and to understand the mechanistic basis for these factors. We analyzed 83 patients with somatic pathogenic variants in UBA1 at p.Met41 (p.Met41Leu\/Thr\/Val), the start codon for translation of the cytoplasmic isoform of UBA1 (UBA1b). Patients with the p.Met41Val genotype were most likely to have an undifferentiated inflammatory syndrome. Multivariate analysis showed ear chondritis was associated with increased survival, whereas transfusion dependence and the p.Met41Val variant were independently associated with decreased survival. Using in\u00a0vitro models and patient-derived cells, we demonstrate that p.Met41Val variant supports less UBA1b translation than either p.Met41Leu or p.Met41Thr, providing a molecular rationale for decreased survival. In addition, we show that these 3 canonical VEXAS variants produce more UBA1b than any of the 6 other possible single-nucleotide variants within this codon. Finally, we report a patient, clinically diagnosed with VEXAS syndrome, with 2 novel mutations in UBA1 occurring in cis on the same allele. One mutation (c.121 A&amp;gt;T; p.Met41Leu) caused severely reduced translation of UBA1b in a reporter assay, but coexpression with the second mutation (c.119 G&amp;gt;C; p.Gly40Ala) rescued UBA1b levels to those of canonical mutations. We conclude that regulation of residual UBA1b translation is fundamental to the pathogenesis of VEXAS syndrome and contributes to disease prognosis.<\/jats:p>","DOI":"10.1182\/blood.2022016985","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T15:01:41Z","timestamp":1657119701000},"page":"1496-1506","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":201,"title":["Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis"],"prefix":"10.1182","volume":"140","author":[{"given":"Marcela A.","family":"Ferrada","sequence":"first","affiliation":[{"name":"1National Institutes of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NHS), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7910-0554","authenticated-orcid":false,"given":"Sinisa","family":"Savic","sequence":"additional","affiliation":[{"name":"2Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, United Kingdom;"},{"name":"3National Institute for Health and Care Research (NIHR)-Leeds Biomedical Research Centre, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Ospina","family":"Cardona","sequence":"additional","affiliation":[{"name":"4National Human Genome Research Institute, National Institutes of Health, Bethesda, MD;"},{"name":"5Center for Human Genetics and Genomics, New York University Grossman School of Medicine, NY, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7653-0070","authenticated-orcid":false,"given":"Jason C.","family":"Collins","sequence":"additional","affiliation":[{"name":"6National Institute of Dental and Craniofacial Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Alessi","sequence":"additional","affiliation":[{"name":"1National Institutes of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NHS), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3116-4588","authenticated-orcid":false,"given":"Fernanda","family":"Gutierrez-Rodrigues","sequence":"additional","affiliation":[{"name":"7National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7210-5811","authenticated-orcid":false,"given":"Dinesh Babu Uthaya","family":"Kumar","sequence":"additional","affiliation":[{"name":"5Center for Human Genetics and Genomics, New York University Grossman School of Medicine, NY, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Wilson","sequence":"additional","affiliation":[{"name":"4National Human Genome Research Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Goodspeed","sequence":"additional","affiliation":[{"name":"1National Institutes of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NHS), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Topilow","sequence":"additional","affiliation":[{"name":"8Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8436-1601","authenticated-orcid":false,"given":"Julie J.","family":"Paik","sequence":"additional","affiliation":[{"name":"8Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2048-5693","authenticated-orcid":false,"given":"James A.","family":"Poulter","sequence":"additional","affiliation":[{"name":"2Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanaz A.","family":"Kermani","sequence":"additional","affiliation":[{"name":"9Division of Rheumatology, University of California Los Angeles, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Koster","sequence":"additional","affiliation":[{"name":"10Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7708-2487","authenticated-orcid":false,"given":"Kenneth J.","family":"Warrington","sequence":"additional","affiliation":[{"name":"10Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Cargo","sequence":"additional","affiliation":[{"name":"11Haematological Malignancy Diagnostic Service, Leeds Cancer Centre, St James\u2019s University Hospital, Leeds, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel S.","family":"Tattersall","sequence":"additional","affiliation":[{"name":"12Sheffield Teaching Hospitals National Institutes of Health (NHS) Foundation, Sheffield, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4181-2315","authenticated-orcid":false,"given":"Christopher J. A.","family":"Duncan","sequence":"additional","affiliation":[{"name":"13Immunity and Inflammation Theme, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cantor","sequence":"additional","affiliation":[{"name":"5Center for Human Genetics and Genomics, New York University Grossman School of Medicine, NY, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"4National Human Genome Research Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5841-778X","authenticated-orcid":false,"given":"Elspeth M.","family":"Payne","sequence":"additional","affiliation":[{"name":"14Research Department of Hematology, Cancer Institute, University College London, London, United Kingdom;"},{"name":"15National Institute for Health and Care Research (NIHR)\/University College London Hospitals (UCLH) Clinical Research Facility, University College London Hospitals National Institutes of Health (NHS) Foundation Trust, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3567-0149","authenticated-orcid":false,"given":"Hanna","family":"Bonnekoh","sequence":"additional","affiliation":[{"name":"16Institute of Allergology, Charite \u2013 Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany;"},{"name":"17Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Allergology and Immunology, Berlin, Germany;"},{"name":"18Autoinflammation Reference Center Charite (ARC2), Charite \u2014 Universit\u00e4tsmedizin Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9711-9654","authenticated-orcid":false,"given":"Karoline","family":"Krause","sequence":"additional","affiliation":[{"name":"16Institute of Allergology, Charite \u2013 Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany;"},{"name":"17Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Allergology and Immunology, Berlin, Germany;"},{"name":"18Autoinflammation Reference Center Charite (ARC2), Charite \u2014 Universit\u00e4tsmedizin Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1918-4324","authenticated-orcid":false,"given":"Edward W.","family":"Cowen","sequence":"additional","affiliation":[{"name":"1National Institutes of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NHS), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine R.","family":"Calvo","sequence":"additional","affiliation":[{"name":"19Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavisha A.","family":"Patel","sequence":"additional","affiliation":[{"name":"7National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda K.","family":"Ombrello","sequence":"additional","affiliation":[{"name":"4National Human Genome Research Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Kastner","sequence":"additional","affiliation":[{"name":"4National Human Genome Research Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal S.","family":"Young","sequence":"additional","affiliation":[{"name":"7National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1051-8447","authenticated-orcid":false,"given":"Achim","family":"Werner","sequence":"additional","affiliation":[{"name":"6National Institute of Dental and Craniofacial Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Grayson","sequence":"additional","affiliation":[{"name":"1National Institutes of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NHS), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5884-6231","authenticated-orcid":false,"given":"David B.","family":"Beck","sequence":"additional","affiliation":[{"name":"4National Human Genome Research Institute, National Institutes of Health, Bethesda, MD;"},{"name":"5Center for Human Genetics and Genomics, New York University Grossman School of Medicine, NY, NY;"},{"name":"20Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, NY, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"27","key":"2022092915292226000_B1","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N Engl J Med."},{"issue":"3","key":"2022092915292226000_B2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/bjd.20805","article-title":"Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients","volume":"186","author":"Georgin-Lavialle","year":"2022","journal-title":"Br J Dermatol."},{"issue":"26","key":"2022092915292226000_B3","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1182\/blood.2020010177","article-title":"Therapeutic options in VEXAS syndrome: insights from a retrospective series","volume":"137","author":"Bourbon","year":"2021","journal-title":"Blood."},{"issue":"8","key":"2022092915292226000_B4","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/annrheumdis-2021-220089","article-title":"Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis","volume":"80","author":"Tsuchida","year":"2021","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"2022092915292226000_B5","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1182\/bloodadvances.2021004749","article-title":"Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience","volume":"6","author":"Diarra","year":"2022","journal-title":"Blood Adv."},{"issue":"6","key":"2022092915292226000_B6","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood."},{"issue":"3","key":"2022092915292226000_B7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00005792-197605000-00001","article-title":"Relapsing polychondritis: prospective study of 23 patients and a review of the literature","volume":"55","author":"McAdam","year":"1976","journal-title":"Medicine (Baltimore)"},{"issue":"6 Pt 1","key":"2022092915292226000_B8","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1288\/00005537-197906000-00009","article-title":"Relapsing polychondritis--report of ten cases","volume":"89","author":"Damiani","year":"1979","journal-title":"Laryngoscope."},{"issue":"20","key":"2022092915292226000_B9","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood."},{"issue":"3","key":"2022092915292226000_B10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1515\/jtim-2017-0002","article-title":"The 2016 revision to the World Health Organization classification of myelodysplastic syndromes","volume":"5","author":"Hong","year":"2017","journal-title":"J Transl Int Med."},{"issue":"17","key":"2022092915292226000_B11","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1101\/gad.305250.117","article-title":"Non-AUG translation: a new start for protein synthesis in eukaryotes","volume":"31","author":"Kearse","year":"2017","journal-title":"Genes Dev."},{"issue":"26","key":"2022092915292226000_B12","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1182\/blood.2020010286","article-title":"Novel somatic mutations in UBA1 as a cause of VEXAS syndrome","volume":"137","author":"Poulter","year":"2021","journal-title":"Blood."},{"issue":"16","key":"2022092915292226000_B13","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1182\/bloodadvances.2021004976","article-title":"Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1","volume":"5","author":"Obiorah","year":"2021","journal-title":"Blood Adv."},{"issue":"11","key":"2022092915292226000_B14","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood.2021011323","article-title":"Relationship between clone metrics and clinical outcome in clonal cytopenia","volume":"138","author":"Gall\u00ec","year":"2021","journal-title":"Blood."},{"issue":"8","key":"2022092915292226000_B15","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1182\/bloodadvances.2020003976","article-title":"Clinical, molecular, and prognostic comparisons between CCUS and lower-risk MDS: a study of 187 molecularly annotated patients","volume":"5","author":"Li","year":"2021","journal-title":"Blood Adv."},{"key":"2022092915292226000_B16","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-022-01258-w","article-title":"A high-throughput amplicon screen for somatic UBA1 variants in cytopenic and giant cell arteritis cohorts [published online ahead of print 2 April 2022]","author":"Poulter","year":"2022","journal-title":"J Clin Immunol."},{"issue":"2","key":"2022092915292226000_B17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood.2020004850","article-title":"SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS","volume":"136","author":"Malcovati","year":"2020","journal-title":"Blood."},{"issue":"3","key":"2022092915292226000_B18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1182\/bloodadvances.2019001101","article-title":"Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes","volume":"4","author":"Montalban-Bravo","year":"2020","journal-title":"Blood Adv."},{"issue":"11","key":"2022092915292226000_B19","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1038\/leu.2016.138","article-title":"Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes","volume":"30","author":"Nazha","year":"2016","journal-title":"Leukemia."},{"issue":"7","key":"2022092915292226000_B20","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/s41436-021-01132-x","article-title":"Clinical relevance of genotype-phenotype correlations beyond vascular events in a cohort study of 1500 Marfan syndrome patients with FBN1 pathogenic variants","volume":"23","author":"Arnaud","year":"2021","journal-title":"Genet Med."},{"issue":"6","key":"2022092915292226000_B21","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.jaci.2019.12.908","article-title":"Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2)","volume":"145","author":"Lee","year":"2020","journal-title":"J Allergy Clin Immunol."},{"key":"2022092915292226000_B22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/TACG.S146022","article-title":"Multiple phenotypic domains of Fabry disease and their relevance for establishing genotype- phenotype correlations","volume":"12","author":"Oliveira","year":"2019","journal-title":"Appl Clin Genet."},{"issue":"4","key":"2022092915292226000_B23","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2011.10.002","article-title":"Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes","volume":"147","author":"Ingolia","year":"2011","journal-title":"Cell."},{"issue":"1","key":"2022092915292226000_B24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1101\/gr.226050.117","article-title":"Discovery of noncanonical translation initiation sites through mass spectrometric analysis of protein N termini","volume":"28","author":"Na","year":"2018","journal-title":"Genome Res."},{"issue":"7809","key":"2022092915292226000_B25","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature."},{"key":"2022092915292226000_B26","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2022016642","article-title":"Ruxolitinib is more effective than other JAK Inhibitors to treat VEXAS Syndrome: a retrospective multi center study [published online ahead of print 24 May 2022]","author":"Heiblig","year":"2022","journal-title":"Blood."},{"issue":"4","key":"2022092915292226000_B27","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/bjh.17893","article-title":"Azacitidine for patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry","volume":"196","author":"Comont","year":"2022","journal-title":"Br J Haematol."},{"issue":"22","key":"2022092915292226000_B28","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1056\/NEJMc2102124","article-title":"Mutant UBA1 and severe adult-onset autoinflammatory disease","volume":"384","author":"Arlet","year":"2021","journal-title":"N Engl J Med."},{"issue":"11","key":"2022092915292226000_B29","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1136\/annrheumdis-2021-220876","article-title":"Tocilizumab in VEXAS relapsing polychondritis: a single-center pilot study in Japan","volume":"80","author":"Kirino","year":"2021","journal-title":"Ann Rheum Dis."},{"issue":"22","key":"2022092915292226000_B30","first-page":"2164","article-title":"Mutant UBA1 and severe adult-onset autoinflammatory disease [reply]","volume":"384","author":"Beck","year":"2021","journal-title":"N Engl J Med."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/140\/13\/1496\/1922843\/bloodbld2022016985.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/140\/13\/1496\/1922843\/bloodbld2022016985.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T02:43:53Z","timestamp":1700793833000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/140\/13\/1496\/485796\/Translation-of-cytoplasmic-UBA1-contributes-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":30,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022,9,29]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2022016985","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,29]]}}}